pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
CRISPR/Cas9 · news · pharmadog
← back to CRISPR/Cas9
News · CRISPR/Cas9
180
stories
25d
New FDA draft guidance doubles down on expediting approvals of personalized gene therapies
biospace
25d
STAT+: Pharmalittle: We’re reading about 340B battles, new results for a Lilly weight loss drug, and more
stat
26d
‘The patient need is enormous’: Syntax programs stem cells into pancreatic beta cells in 4 days
fiercebiotech
26d
FDA issues draft guidance on individualized gene editing products to fill ‘critical gap’
raps
Oct 21, 26
Nigeria identifies travel-related Ebola case
stat
Oct 21, 26
STAT+: Mark Cuban wants to crack open the market for rare disease treatments
stat
Oct 20, 26
Most new drugs are still too costly at launch, ICER says
biopharma dive
Oct 20, 26
Lilly puts $1.1B on the line for Hong Kong biotech’s AI drug delivery platform
biospace
Oct 19, 26
From strategy to scale: How Saudi Arabia is building a biotech ecosystem
biopharma dive
Oct 15, 26
Chutes & Ladders—Bausch + Lomb's returning CEO Saunders exits again
fiercebiotech
Oct 14, 26
As White House shifts focus toward AI and tech, U.S. science leaders defend role of the American university
stat
Oct 14, 26
J&J’s disappointing Q3, RevMed’s subgroup data, BMS’ ‘mixed’ results, Caribou’s cutback
biospace
Oct 13, 26
Beam suggests it can correct mutation; Pfizer to collaborate with Enodia
endpoints
Oct 8, 26
Reusing data could cut R&D costs and greatly increase gene editing’s reach: ARM
biospace
Oct 8, 26
NIH funding uncertainty thwarts U.S. researchers
stat
Oct 8, 26
In the hunt for reverse merger targets, Caribou could be prized game
biopharma dive
Oct 7, 26
Caribou to halt CAR-T work, lay off staff amid ‘challenging’ funding climate
biopharma dive
Oct 7, 26
STAT+: Pharmalittle: We’re reading about WHO obesity guidelines for kids, DOJ targeting pharma, and more
stat
Oct 7, 26
Doudna’s CAR T biotech Caribou to end R&D activities, slash staff as financing freezes up
biospace
Oct 7, 26
STAT+: Caribou Biosciences, biotech co-founded by Jennifer Doudna, is shutting down
stat
Oct 6, 26
CAR-T biotech Caribou makes ‘heartbreaking’ call to shrink headcount, halt pipeline
fiercebiotech
Oct 5, 26
Epicrispr builds case for FSHD treatment with updated data for EPI-321
endpoints
Oct 1, 26
Mistrust in science and a juicy gene-editing lawsuit
stat
Sep 30, 26
STAT+: Pharmalittle: We’re reading about Beam suing over IP theft, a Trump rule on importing meds, and more
stat
Sep 30, 26
Beam Therapeutics sues base editing rival, claims former scientist stole secrets
fiercebiotech
Sep 29, 26
Beam sues YolTech and Serapha Bio for allegedly stealing its gene editing tech
endpoints
Sep 29, 26
Beam sues 2 biotechs, alleging theft of base editing trade secrets
biopharma dive
Sep 29, 26
Researchers slow neurodegeneration in mice by barring T cells from the brain
stat
Sep 28, 26
Trump uses ‘contested’ power to cut more funding to HHS
stat
Sep 25, 26
Endpoints 11 2026 winner Azalea melds gene editing and CAR-T
endpoints
← prev
page 2 of 6
next →